Antibodies directed to HER-3 and uses thereof

Details for Australian Patent Application No. 2006332065 (hide)

Owner Amgen Inc. U3 Pharma GmbH

Inventors Rothe, Mike; Borges, Eric; Hartmann, Susanne; Freeman, Dan; Radinsky, Bob; Treder, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2006332065

PCT Pub. Number WO2007/077028

Priority 60/755,103 30.12.05 US

Filing date 29 December 2006

Wipo publication date 12 July 2007

Acceptance publication date 12 April 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/43 (2006.01) Peptides having more than 20 amino acids

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/077028 Priority application(s): WO2007/077028

18 June 2009 Alteration of Name

  The name of the applicant has been altered to Amgen Inc.; U3 Pharma GmbH 2007

12 April 2012 Application Accepted

  Published as AU-B-2006332065

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332066-Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers

2006332050-A spacer and associated apparatus and method